Co-Diagnostics
(NASDAQ) CODX
Co-Diagnostics Financials at a Glance
Market Cap
$6.95M
Revenue (TTM)
$622.49K
Net Income (TTM)
$46.90M
EPS (TTM)
$-31.01
P/E Ratio
-0.06
Dividend
$0.00
Beta (Volatility)
1.30 (Average)
Dividend
$0.00
Beta (Volatility)
1.30 (Average)
Price
$1.92
Volume
4,892
Open
$1.72
Price
$1.92
Volume
4,892
Open
$1.72
Previous Close
$1.92
Daily Range
$1.72 - $1.99
52-Week Range
$1.35 - $46.50
Dividend
$0.00
Beta (Volatility)
1.30 (Average)
Price
$1.92
Volume
4,892
Open
$1.72
Previous Close
$1.92
Daily Range
$1.72 - $1.99
52-Week Range
$1.35 - $46.50
CODX News
Why Co-Diagnostics Is Soaring Today
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Co-Diagnostics
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
115
CEO
Dwight Howard Egan
Website
co-dx.comHeadquarters
Salt Lake City, UT 84109, US
CODX Financials
Key Financial Metrics (TTM)
Gross Margin
64%
Operating Margin
-50%
Net Income Margin
-75%
Return on Equity
-125%
Return on Capital
-1%
Return on Assets
-2%
Earnings Yield
-16.67%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.95M
Shares Outstanding
3.60M
Volume
4.89K
Avg. Volume
1.80M
Financials (TTM)
Gross Profit
$400.11K
Operating Income
$31.28M
EBITDA
$30.18M
Operating Cash Flow
$29.14M
Capital Expenditure
$700.05K
Free Cash Flow
$29.84M
Cash & ST Invst.
$11.88M
Total Debt
$1.24M
Co-Diagnostics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$263.92K
+76.7%
Gross Profit
$121.53K
+214.9%
Gross Margin
46.05%
N/A
Market Cap
$6.95M
N/A
Market Cap/Employee
$52.67K
N/A
Employees
132
N/A
Net Income
$25.75M
-133.4%
EBITDA
$7.39M
+36.0%
Quarterly Fundamentals
Net Cash
$10.65M
-61.4%
Accounts Receivable
$190.38K
+43.6%
Inventory
$992.40K
-7.5%
Long Term Debt
$574.30K
-53.6%
Short Term Debt
$662.26K
-27.7%
Return on Assets
-1.90%
N/A
Return on Invested Capital
-1.48%
N/A
Free Cash Flow
$6.33M
+23.8%
Operating Cash Flow
$6.20M
+24.7%